These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 33475899)
1. A preliminary clinical trial to evaluate Lee I; Lim I; Byun BH; Kim BI; Choi CW; Woo SK; Kim KI; Lee KC; Kang JH; Seong MK; Kim HA; Noh WC; Lim SM EJNMMI Res; 2021 Jan; 11(1):8. PubMed ID: 33475899 [TBL] [Abstract][Full Text] [Related]
2. Development of Woo SK; Jang SJ; Seo MJ; Park JH; Kim BS; Kim EJ; Lee YJ; Lee TS; An GI; Song IH; Seo Y; Kim KI; Kang JH J Nucl Med; 2019 Jan; 60(1):26-33. PubMed ID: 29777007 [TBL] [Abstract][Full Text] [Related]
3. A microdose clinical trial to evaluate [ Lee I; Lim I; Byun BH; Kim BI; Choi CW; Woo SK; Lee KC; Kang JH; Kil HS; Park C; Chi DY; Park J; Song K; Lim SM Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):95-102. PubMed ID: 32458006 [TBL] [Abstract][Full Text] [Related]
4. Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET. Mortimer JE; Bading JR; Colcher DM; Conti PS; Frankel PH; Carroll MI; Tong S; Poku E; Miles JK; Shively JE; Raubitschek AA J Nucl Med; 2014 Jan; 55(1):23-9. PubMed ID: 24337604 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer. Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015 [TBL] [Abstract][Full Text] [Related]
6. Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma. Keyaerts M; Xavier C; Heemskerk J; Devoogdt N; Everaert H; Ackaert C; Vanhoeij M; Duhoux FP; Gevaert T; Simon P; Schallier D; Fontaine C; Vaneycken I; Vanhove C; De Greve J; Lamote J; Caveliers V; Lahoutte T J Nucl Med; 2016 Jan; 57(1):27-33. PubMed ID: 26449837 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive Detection of HER2 Expression in Gastric Cancer by Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865 [TBL] [Abstract][Full Text] [Related]
8. Development and preclinical studies of Lam K; Chan C; Reilly RM MAbs; 2017 Jan; 9(1):154-164. PubMed ID: 27813707 [TBL] [Abstract][Full Text] [Related]
9. Comparison of renal clearance of [ Liu J; Guo X; Wen L; Wang L; Liu F; Song G; Zhu H; Zhou N; Yang Z Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2775-2786. PubMed ID: 37093312 [TBL] [Abstract][Full Text] [Related]
10. [ Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Dekervel J; Van Cutsem E; Verslype C; Van Laere K; Bormans G; Deroose CM Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3033-3046. PubMed ID: 32617641 [TBL] [Abstract][Full Text] [Related]
17. Prospective Study of (68)Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients. Wang Z; Zhang M; Wang L; Wang S; Kang F; Li G; Jacobson O; Niu G; Yang W; Wang J; Chen X Theranostics; 2015; 5(8):882-9. PubMed ID: 26000059 [TBL] [Abstract][Full Text] [Related]
18. Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients. Sandström M; Lindskog K; Velikyan I; Wennborg A; Feldwisch J; Sandberg D; Tolmachev V; Orlova A; Sörensen J; Carlsson J; Lindman H; Lubberink M J Nucl Med; 2016 Jun; 57(6):867-71. PubMed ID: 26912439 [TBL] [Abstract][Full Text] [Related]
20. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging. Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]